HOLMES HERBS, INC.: QUALIA COMPLETES RESEARCH CONTRACT FOR MERCK PHARMACEUTICALS

Holmes Herbs, Inc., (OTCBB:HMHB), announced today that its clinical research partner, Qualia Clinical Research Services Inc. ("Qualia"), recently completed a clinical research contract on behalf of Merck Pharmaceuticals. The clinical research for Merck Pharmaceuticals involved a Phase 4 trial on Monteleukast. Merck is a leading research-driven pharmaceutical company engaged in discovering, developing, manufacturing and marketing medicines for human health.

CCNMatthews (http://www.ccnmatthews.com/news/releasesfr/show.jsp?action=showRelease&searchText=false&showText=all&actionFor=566972)